This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: S&k Therapeutics. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Chang Hee Suh - Innovator in Peptide Therapeutics
Introduction
Chang Hee Suh is a notable inventor based in South Korea, recognized for his contributions to the field of peptide therapeutics. His work primarily focuses on developing innovative solutions for autoimmune and inflammatory diseases. Despite having 1 patents, his research has significant implications for therapeutic applications.
Latest Patents
One of his key inventions is related to peptide therapeutics for autoimmune diseases and inflammatory diseases. This invention involves a peptide that inhibits a Toll-like receptor (TLR) signaling pathway. Specifically, it targets the TLR4 signaling pathway, which is crucial in the immune response. The invention includes a peptide that binds strongly to a TIR-containing molecule to inhibit TLR4, a fusion peptide that combines a cell-penetrating peptide with the original peptide, and a TLR4 antagonist that comprises either the peptide or the fusion peptide. Additionally, it presents a composition aimed at preventing or treating autoimmune and inflammatory diseases.
Career Highlights
Chang Hee Suh's research demonstrates a substantial inhibitory effect on various TLR signaling pathways, including TLR4. His findings indicate that the peptide can block MyD88- and TRIF-dependent TLR4 pathways. Furthermore, it has shown a significant disease-alleviating effect in mouse models of rheumatoid arthritis, psoriasis, systemic lupus erythematosus, and non-alcoholic steatohepatitis. This positions his work as a promising avenue for developing therapeutics that require negative control of TLR.
Collaborations
Chang Hee Suh has collaborated with Wook Kim, contributing to the advancement of peptide therapeutics. Their joint efforts have focused on enhancing the efficacy of treatments for immune-related diseases.
Conclusion
Chang Hee Suh's innovative work in peptide therapeutics highlights the potential for new treatments for autoimmune and inflammatory diseases. His research could pave the way for significant advancements in therapeutic strategies.